Login / Signup

Intratympanic Botulinum Toxin Injection as a New Therapeutic Modality for Middle Ear Myoclonic Tinnitus.

Jung M ParkMin J KimJae S HanSo Y ParkShi Nae Park
Published in: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023)
The new therapeutic modality of IT-BTX injection for the treatment of MEMT seems highly promising with an excellent result.
Keyphrases
  • botulinum toxin
  • ultrasound guided
  • combination therapy
  • hearing loss